Are the New Nucleos(t)ide Analogs Better than the Old Nucleos(t)ide Analogs?

被引：0
作者：
Choi, Jonggi [1 ]
Choi, Won-Mook [1 ]
Lim, Young-Suk [1 ]
机构：
[1] Univ Ulsan, Asan Med Ctr, Dept Gastroenterol, Coll Med, 88, Olymp Ro 43-gil, Seoul 05505, South Korea
来源：
CLINICS IN LIVER DISEASE | 2023年 / 27卷 / 04期
关键词：
Lamivudine; Adefovir; Entecavir; Tenofovir; Hepatitis B; Hepatocellular carcinoma; CHRONIC HEPATITIS-B; TENOFOVIR DISOPROXIL FUMARATE; HEPATOCELLULAR-CARCINOMA; DOUBLE-BLIND; ANTIVIRAL THERAPY; VIRUS INFECTION; ENTECAVIR; ALAFENAMIDE; RESISTANCE; PHASE-3;
D O I：
10.1016/j.cld.2023.05.005
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：809 / 818
页数：10
相关论文
共 50 条
[41]   Performance of serum HBcrAg in chronic hepatitis B patients with 8-year nucleos(t)ide analogs therapy [J].
Wang, Meng-Lan ;
Deng, Rong ;
Chen, En-Qiang ;
Tao, Chuan-Min ;
Liao, Juan ;
Zhou, Tao-You ;
Wang, Juan ;
Tang, Hong .
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2019, 43 (03) :301-309
[42]   Effect of Nucleos(t)ide Analogs on Patients with Intermediate and Advanced Hepatitis B Virus-Related Hepatocellular Carcinoma [J].
Jian, Zhi-Wei ;
Wu, Xi-Wen ;
Chen, Zhen-Xin ;
Wang, Jun-Cheng ;
Peng, Jing-Yuan ;
Lao, Xiang-Ming .
DIGESTIVE DISEASES AND SCIENCES, 2019, 64 (08) :2187-2198
[43]   Risk for hepatocellular carcinoma in the course of chronic hepatitis B virus infection and the protective effect of therapy with nucleos(t)ide analogues [J].
Irene Rapti ;
Stephanos Hadziyannis .
World Journal of Hepatology, 2015, 7 (08) :1064-1073
[44]   Potential use of serum HBV RNA in antiviral therapy for chronic hepatitis B in the era of nucleos(t)ide analogs [J].
Lu, Fengmin ;
Wang, Jie ;
Chen, Xiangmei ;
Xu, Dongping ;
Xia, Ningshao .
FRONTIERS OF MEDICINE, 2017, 11 (04) :502-508
[45]   Pronounced decline of serum HBsAg in chronic hepatitis B patients with long-term effective nucleos(t)ide analogs therapy [J].
Wang, Meng-Lan ;
Chen, En-Qiang ;
Tao, Chuan-Min ;
Zhou, Tao-You ;
Liao, Juan ;
Zhang, Dong-Mei ;
Wang, Juan ;
Tang, Hong .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2017, 52 (12) :1420-1426
[46]   Histological response to combination therapy with nucleos(t)ide analogs and peginterferon alpha in treatment-naive chronic hepatitis B patients [J].
Zhang, Qiran ;
Li, Guojun ;
Yu, Yiqi ;
Qiu, Chao ;
Zheng, Jianming ;
Zhang, Hanyue ;
Zhang, Miaoqu ;
Song, Zhangzhang ;
Yang, Yusheng ;
Du, Xinfang ;
Hong, Jiemin ;
Lu, Jian ;
Li, Niuniu ;
Tang, Quanzhen ;
Xu, Long ;
Wang, Xuanyi ;
Huang, Yuxian ;
Zhang, Jiming ;
Chen, Zhi ;
Zhang, Wenhong .
JOURNAL OF VIRAL HEPATITIS, 2019, 26 :59-68
[47]   Risk for hepatocellular carcinoma in the course of chronic hepatitis B virus infection and the protective effect of therapy with nucleos(t)ide analogues [J].
Rapti, Irene ;
Hadziyannis, Stephanos .
WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (08) :1064-1073
[48]   Is it possible to stop nucleos(t)ide analogue treatment in chronic hepatitis B patients? [J].
Elia Moreno-Cubero ;
Robert T Sánchez del Arco ;
Julia Pe?a-Asensio ;
Eduardo Sanz de Villalobos ;
Joaquín Míquel ;
Juan Ramón Larrubia .
World Journal of Gastroenterology, 2018, 24 (17) :1825-1838
[49]   High percentage atypical hepatocellular carcinoma in chronic hepatitis B patients treated with nucleos(t)ide analogs [J].
Lin, Ching-Chung ;
Bair, Ming-Jong ;
Liu, Chia-Yuan ;
Lin, Ze-Yu ;
Chen, Chih-Jen ;
Chen, Ming-Jen ;
Chu, Cheng-Hsin ;
Wang, Horng-Yuan ;
Shih, Shou-Chuan ;
Wang, Tsang-En .
MEDICINE, 2019, 98 (01) :E13818
[50]   FIB-4 index and serum α-fetoprotein are useful predictors of hepatocellular carcinoma occurrence in hepatitis B patients with nucleos(t)ide analogs therapy [J].
Kuwano, Akifumi ;
Miyazaki, Masayuki ;
Yada, Masayoshi ;
Tanaka, Kosuke ;
Koga, Yuta ;
Masumoto, Akihide ;
Motomura, Kenta .
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2023, 26 (03)
12345